Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 4

Sponsor Class

OTHER 6INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

Inosine Monophosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Low Back Pain × Clear all
NCT03031938 2021-06-25

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Pfizer

Phase 3 Completed
4 enrolled 78 charts

Cancer Pain, Osteoarthritis, Low Back Pain

NCT02367820 2021-06-22

SUMMIT-LTS

Nektar Therapeutics

Phase 3 Completed
638 enrolled 12 charts

Low Back Pain, Chronic Pain

NCT02519387 2016-07-20

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

Mundipharma Pharmaceuticals Sdn. Bhd.

Phase 4 Completed
78 enrolled 9 charts

Arthritis, Rheumatoid, Osteoarthritis, Low Back Pain, Arthralgia, Myalgia

NCT00904280 2009-05-19

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

Endo Pharmaceuticals

Phase 3 Completed
239 enrolled

Neoplasms, Pain, Low Back Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡